EVMN
EVMN
NYSE · Biotechnology

Evommune Inc

$5.94
-0.07 (-1.16%)
As of Nov 7, 2:01 AM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 15 83%
Hold 3 17%
Sell 0 0%
Price Target
Analyst Price Target +1,176.1% upside
Low Target $52.19
Average Target $75.80
High Target $91.23
Current Price $5.94
Current
$5.94
Target
$75.80
$52.19 $75.80 avg $91.23
Scenario Analysis
Bear Case
$52.19
778.6%
Low target
Base Case
$75.80
+1,176.1%
Avg target
Bull Case
$91.23
+1,435.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$33.20
-82.1% from high
52-Week Low
$4.94
+20.2% from low
Target vs 52W High
$75.80
+128.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%